APL is a distinct subtype of myeloid leukaemia that in almost 100% of cases is associated with chromosomal translocations involving the PML and retinoic acid receptor α (RARA) loci, leading to the ...

July 1, 2008 (July 2, 2008) — Updates have been approved to the safety labeling for mycophenolate mofetil (CellCept, Hoffman-LaRoche, Inc) and its metabolite mycophenolic acid (Myfortic, Novartis ...